Human cytomegalovirus (CMV) is a double-stranded DNA virus and member of the herpes
virus family. Infection prevalence reaches 60% to 80% by adulthood in the United States and …

Cytomegalovirus (CMV), a double-stranded DNA virus, is one of the most common infections
that adversely affect the outcome of solid organ transplantation (SOT). It is the fifth member …

Cytomegalovirus (CMV) is the most common opportu-nistic infection occurring after
transplantation. The incidence of CMV disease is between 20% and 60% depending on the …

Cytomegalovirus (CMV) is a ubiquitousherpes virus that infects the majority of humans (1).
The seroprevalence rates of CMV ranges from 30–97%(2, 3). Primary infection manifests as …

Background: Cytomegalovirus (CMV) infection of solid organ transplant (SOT) recipients
causes both ''direct''and ''indirect''effects including allograft rejection, decreased graft and …

Recent advances in cytomegalovirus infection management in s... : Current Opinion in Organ
Transplantation Recent advances in cytomegalovirus infection management in solid organ …

The introduction and combination of more-potent immunosuppressive regimens, and the
increased transplantation of organs into more severely ill patients, have again placed …

Cytomegalovirus (CMV) is the single most important pathogen affecting solid organ
transplant (SOT) recipients. CMV may occur as a primary infection in CMV-naïve patients …

In the past three decades since the inception of human organ transplantation,
cytomegalovirus (CMV) has gained increasing clinical import because it is a common …

Cytomegalovirus (CMV) continues to have a tremendous impact in solid organ
transplantation despite remarkable advances in its diagnosis, prevention and treatment. It …